Dallas-Based Colossal Biosciences Launches Global Biobank for Endangered Species

Want the full story?
Read the complete article at KVIA
AI Summary
Colossal Biosciences, a biotechnology firm based in Dallas, is establishing a biobank in Dubai, UAE, aimed at preserving endangered species. This facility will store millions of frozen tissues from 10,000 species, focusing on the 100 most threatened globally. Following their recent achievement of 'reviving' the extinct dire wolf, Colossal plans to use the biobank for both research and potential de-extinction efforts. The initiative is part of a larger $615 million investment strategy, with a goal to safeguard genetic diversity and address the rapid extinction rates affecting ecosystems worldwide. Experts emphasize the need for international cooperation and regulatory frameworks to ensure the biobank's success and sustainability.
Key Details: • Biobank located in the Museum of the Future, Dubai, UAE. • Focus on preserving samples from 10,000 species, including 100 endangered species. • Colossal has raised $615 million since its inception in 2021. • Experts stress the importance of regulatory frameworks for biobanks.